We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
-1.84%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$227M
AUM Growth
-$55.7M
Cap. Flow
-$49.7M
Cap. Flow %
-21.93%
Top 10 Hldgs %
50.08%
Holding
105
New
12
Increased
23
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$2.18M
2
ARGX icon
argenx
ARGX
+$1.58M
3
ALT icon
Altimmune
ALT
+$1.14M
4
AAPL icon
Apple
AAPL
+$1.1M
5
XNCR icon
Xencor
XNCR
+$1.08M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.93M
2
KIN
Kindred Biosciences, Inc.
KIN
+$3.32M
3
ORCL icon
Oracle
ORCL
+$1.99M
4
GLD icon
SPDR Gold Trust
GLD
+$1.67M
5
AMD icon
Advanced Micro Devices
AMD
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 38.05%
2 Technology 12.14%
3 Communication Services 8.72%
4 Financials 5.36%
5 Consumer Discretionary 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.02T
$2.6M 1.15%
11,250
– –
AOD
27
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.52M 1.11%
259,000
-11,000
-4% -$113K
AMGN icon
28
Amgen
AMGN
$208B
$2.39M 1.06%
11,250
– –
SGEN
29
DELISTED
Seagen Inc. Common Stock
SGEN
$2.29M 1.01%
13,500
– –
BABA icon
30
Alibaba
BABA
$293B
$2.15M 0.95%
14,500
+4,500
+45% +$819K
LNSR icon
31
LENSAR
LNSR
$61.5M
$2.14M 0.94%
279,788
– –
BMY icon
32
Bristol-Myers Squibb
BMY
$133B
$1.92M 0.85%
32,500
-8,000
-20% -$527K
F icon
33
Ford
F
$58.5B
$1.88M 0.83%
132,500
+42,500
+47% +$578K
IMPL
34
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$1.83M 0.81%
+150,000
New +$2.18M
AAPL icon
35
Apple
AAPL
$4.54T
$1.77M 0.78%
12,500
+7,500
+150% +$1.1M
SLV icon
36
iShares Silver Trust
SLV
$28B
$1.64M 0.72%
80,000
+20,000
+33% +$450K
T icon
37
AT&T
T
$159B
$1.62M 0.72%
79,440
– –
AERI
38
DELISTED
Aerie Pharmaceuticals
AERI
$1.56M 0.69%
136,501
+45,201
+50% +$661K
GDXJ icon
39
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$1.53M 0.68%
40,000
-10,000
-20% -$429K
EQ icon
40
Equillium
EQ
$139M
$1.27M 0.56%
185,666
+108,128
+139% +$638K
VIR icon
41
Vir Biotechnology
VIR
$1.46B
$1.22M 0.54%
28,000
+15,929
+132% +$690K
MS icon
42
Morgan Stanley
MS
$331B
$1.22M 0.54%
12,500
-10,000
-44% -$991K
BABA icon
43
CALL
Alibaba
BABA
$293B
$1.11M 0.49%
7,500
+2,000
+36% +$364K
STEW
44
SRH Total Return Fund
STEW
$1.79B
$1.09M 0.48%
83,000
-7,000
-8% -$95.6K
MRVL icon
45
Marvell Technology
MRVL
$168B
$1.05M 0.47%
17,500
– –
PG icon
46
PUT
Procter & Gamble
PG
$336B
$1.05M 0.46%
+7,500
New +$1.06M
AMZN icon
47
CALL
Amazon
AMZN
$2.92T
$986K 0.44%
6,000
-16,000
-73% -$2.76M
QCOM icon
48
Qualcomm
QCOM
$155B
$967K 0.43%
7,500
– –
PSFE icon
49
Paysafe
PSFE
$414M
$853K 0.38%
9,167
– –
NOK icon
50
Nokia
NOK
$51B
$818K 0.36%
150,000
– –
1
2
3 4 5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, DCF Advisers held 105 positions worth $227M, down 20% from $282M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers withdrew a net $49.7M in Q3 2021, closing 24 positions and reducing 19 holdings. Its most notable exit was Kindred Biosciences, Inc., an estimated $3.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in Impel Pharmaceuticals Inc. Common Stock worth $1.83M.

  • DCF Advisers's largest Q3 2021 buy was Impel Pharmaceuticals Inc. Common Stock: 150,000 shares worth $1.83M.
  • DCF Advisers added most to argenx in Q3 2021, an estimated $1.58M increase.
  • DCF Advisers's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $5.93M.
  • DCF Advisers fully exited Kindred Biosciences, Inc. in Q3 2021, selling an estimated $3.32M.
  • DCF Advisers's ten largest holdings make up 50% of its $227M portfolio in Q3 2021.
  • DCF Advisers opened 12 new positions and closed 24 in Q3 2021.
  • DCF Advisers's portfolio value fell 20% quarter-over-quarter to $227M.

Based on DCF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.